JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 25, 2008; DOI: 10.1124/jpet.108.146712

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Ren, J.
Right arrow Articles by Jackson, E. K
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, J.
Right arrow Articles by Jackson, E. K


Received for publication October 3, 2008.
Revised November 24, 2008.
Accepted for publication November 24, 2008.

Identification and Quantification of 2',3'-cAMP Release by the Kidney

Jin Ren 1, Zaichuan Mi 1, Nicolas A Stewart 1, Edwin K Jackson 1*

1 University of Pittsburgh

* Address correspondence to: E-mail: edj{at}pitt.edu

Abstract

We recently developed a sensitive assay for 3',5'-cAMP using high performance liquid chromatography-tandem mass spectrometry. Using this assay, we investigated the release of 3',5'-cAMP from isolated, perfused rat kidneys. To our surprise, we observed a dominant chromatographic peak that was due to an endogenous substance that had the same parent ion as 3',5'-cAMP and that fragmented to the same daughter ion (adenine) as 3',5'-cAMP. However, the retention time of this unknown was approximately 2.9 minutes compared to 6.3 minutes for authentic 3',5'-cAMP. We hypothesized that the unknown substance was an isomer of 3',5'-cAMP. Indeed, the unknown substance had the same retention time and mass spectral properties as authentic 2',3'-cAMP. Renal venous secretion of 2',3'-cAMP was greater in kidneys from 20-week-old genetically-hypertensive rats compared with age-matched normotensive rats (12.49 ± 2.14 versus 5.32 ± 1.97 ng/min per gram kidney weight, respectively; n=18). Isoproterenol (1 µmol/L; {beta}-adrenoceptor agonist) increased renal venous 3',5'-cAMP secretion (approximately 690% of control), but had no effect on 2',3'-cAMP production. In contrast, rapamycin (0.2 µmol/L; activator of mRNA turnover) and iodoacetate + 2,4-dinitrophenol (50 µmol/L; metabolic inhibitors) increased the renal venous secretion of 2',3'-cAMP (approximately 1000% and 4100% of control, respectively) while simultaneously decreasing the renal venous secretion of 3',5'-cAMP. In conclusion, 2',3'-cAMP is a naturally-occurring isomer of 3',5'-cAMP that is: 1) not made by adenylyl cyclase; 2) released from kidneys into the extracellular compartment; 3) released more by kidneys from rats with long-standing hypertension; 4) derived from mRNA turnover; and 5) increased by energy depletion.


Key words: adenosine 2',3'-cyclic monophosphate, adenosine 3',5'-cyclic monophosphate, isolated, perfused kidney, kidney, spontaneously hypertensive rat, tandem liquid chromatography-mass spectrometry





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.